As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
2017 was a year for the books! Our sponsors continue to receive regulatory approvals maximizing their investment in preclinical research, and our bioskills training program continues to ensure physicians and surgeons develop the skills required to fully realize the value of the medtech innovations. As we put a bow on a remarkable year, we want…
Grants season is coming up again! Let’s face it, preparing and submitting a biomedical research grant application is a tedious task that requires a lot of planning. We at GCMI-T3 get dozens of requests every year to be collaborators on the preclinical portion of the grant application, often times the night before the grant is…
For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Depending on the class and type of submission, not every medical product requires preclinical studies, however, completing preclinical studies is advantageous for proof of concept, when raising capital, applying for reimbursement, and…
The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies. The 2017 edition was no exception. This was the second year that GCMI and T3 Labs has had a booth during TCT, and we stand…
Starting Sunday, October 29, industry leaders in transcatheter cardiovascular innovation will convene in Denver, Colorado for TCT 2017. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center for transcatheter innovation and education. The goal? As always, to improve patient care.…
Connect with GCMI and T3 Labs during the 2017 edition of the Georgia Bio Innovation Summit Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. What will the future of innovation mean for the healthcare industry as a…
Connect with T3 Labs during ACG 2017- Booth #526 The American College of Gastroenterology is a recognized leader in educating GI professionals and the general public about digestive disorders. Starting Thursday, October 12 in Orlando, Florida, industry leaders across the spectrum of gastroenterology and GI will gather at ACG 2017, the American College of Gastroenterology…
We wish to extend a huge congratulations to our sponsor ALung Technologies! Just last week, it was announced that ALung has received IDE approval to conduct a VENT-AVOID trial of the Hemolung RAS for the US Market. The device, which achieved its CE mark in 2013, permitting sales throughout the EU, is the world’s first…
“Children aren’t little adults, yet we expect our physicians to retrofit adult devices to fit a pediatric patient,” says Sherry Farrugia, Chief Operating and Strategy Officer of the Pediatric Technology Center, and Director of Children’s Healthcare of Atlanta Partnership. “When adult devices are used it can often cause safety concerns in surgery, orthopedics – really…
Through Project ENGAGES, a select group of high school students experience the biomedical community and the full view of the medical product pathway: from bench to bedside. On July 12th, GCMI and its subsidiary T3 Labs, hosted 30 high school students who are a part of Project ENGAGES- a year long program for high school…